Interaction of septadian and circadian rhythms in life-threatening ventricular arrhythmias in patients with implantable cardioverter-defibrillators

被引:21
作者
Peters, RW
McQuillan, S
Gold, MR
机构
[1] Dept Vet Affairs Med Ctr, Div Cardiol, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21201 USA
[3] Guidant Corp, Clin Programs Dept, St Paul, MN USA
关键词
D O I
10.1016/S0002-9149(99)00376-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previous studies have shown that life-threatening ventricular arrhythmias display both circadian and septadian (day of the week) periodicity. We hypothesized that assessing the relation between these circadian and septadian rhythms may provide important pathophysiologic information about the mechanism of sudden cardiac death. Using the database from a population of 683 consecutive patients with a third-generation implantable cardioverter-defibrillator (ICD), we examined the time pattern of ICD activations for rapid (prospectively defined as cycle length <280 ms) tachycardias for each day of the week. A total of 5,270 arrhythmic episodes were analyzed. Despite the fact that event distribution was significantly nonuniform (p <0.001) for both circadian and septadian analyses, the circadian pattern was strikingly similar for each day df the week with a relatively broad peak between 9 A.M. and 6 P.M, and a long nadir between 9 P.M, and 6 A.M. We conclude that the trigger factors responsible for the daily circadian distribution of life-threatening ventricular arrhythmias in a population with ICDs are similar throughout the week and may thus be unrelated to the standard work week. These data suggest that the physiologic modulators of circadian and septadian rhythms may be different. (C) 1999 by Excerpta Medico, Inc.
引用
收藏
页码:555 / 557
页数:3
相关论文
共 19 条
[1]   ELECTROPHYSIOLOGIC TESTING AND FOLLOW-UP OF PATIENTS WITH ABORTED SUDDEN-DEATH [J].
ELDAR, M ;
SAUVE, MJ ;
SCHEINMAN, MM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (02) :291-298
[2]   CIRCADIAN VARIATION OF VENTRICULAR-TACHYCARDIA IN ACUTE MYOCARDIAL-INFARCTION [J].
LUCENTE, M ;
REBUZZI, AG ;
LANZA, GA ;
TAMBURI, S ;
CORTELLESSA, MC ;
COPPOLA, E ;
IANNARELLI, M ;
MANZOLI, U .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (10) :670-674
[3]   ELECTROPHYSIOLOGIC TESTING IN THE MANAGEMENT OF SURVIVORS OF OUT-OF-HOSPITAL CARDIAC-ARREST [J].
MORADY, F ;
SCHEINMAN, MM ;
HESS, DS ;
SUNG, RJ ;
SHEN, E ;
SHAPIRO, W .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (01) :85-89
[4]   CIRCADIAN VARIATION IN THE FREQUENCY OF SUDDEN CARDIAC DEATH [J].
MULLER, JE ;
LUDMER, PL ;
WILLICH, SN ;
TOFLER, GH ;
AYLMER, G ;
KLANGOS, I ;
STONE, PH .
CIRCULATION, 1987, 75 (01) :131-138
[5]   TRIGGERS, ACUTE RISK-FACTORS AND VULNERABLE PLAQUES - THE LEXICON OF A NEW FRONTIER [J].
MULLER, JE ;
ABELA, GS ;
NESTO, RW ;
TOFLER, GH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (03) :809-813
[6]   CIRCADIAN VARIATION IN THE FREQUENCY OF ONSET OF ACUTE MYOCARDIAL-INFARCTION [J].
MULLER, JE ;
STONE, PH ;
TURI, ZG ;
RUTHERFORD, JD ;
CZEISLER, CA ;
PARKER, C ;
POOLE, WK ;
PASSAMANI, E ;
ROBERTS, R ;
ROBERTSON, T ;
SOBEL, BE ;
WILLERSON, JT ;
BRAUNWALD, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (21) :1315-1322
[7]   Chronobiology of acute myocardial infarction: Cardiac Arrhythmia Suppression Trial (CAST) experience [J].
Peters, RW ;
Brooks, MM ;
Zoble, RG ;
Liebson, PR ;
Seals, AA .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (11) :1198-1201
[8]   IDENTIFICATION OF A SECONDARY PEAK IN MYOCARDIAL-INFARCTION ONSET 11 TO 12 HOURS AFTER AWAKENING - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL (CAST) EXPERIENCE [J].
PETERS, RW ;
ZOBLE, RG ;
LIEBSON, PR ;
PAWITAN, Y ;
BROOKS, MM ;
PROSCHAN, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) :998-1003
[9]   Increased Monday incidence of life-threatening ventricular arrhythmias - Experience with a third-generation implantable defibrillator [J].
Peters, RW ;
McQuillan, S ;
Resnick, SK ;
Gold, MR .
CIRCULATION, 1996, 94 (06) :1346-1349
[10]   CIRCADIAN PATTERN OF ARRHYTHMIC DEATH IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE OR MORICIZINE IN THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL (CAST) [J].
PETERS, RW ;
MITCHELL, LB ;
BROOKS, MM ;
ECHT, DS ;
BARKER, AH ;
CAPONE, R ;
LIEBSON, PR ;
GREENE, HL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (02) :283-289